Skip to main content
SpringerLink
Log in

Dual drug interactions via P-glycoprotein (P-gp)/ cytochrome P450 (CYP3A4) interplay: recent case study of oral atorvastatin and verapamil

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Choi DH, Shin WG, Choi JS (2008) Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil. Eur J Clin Pharmacol 64:445–449

    Article  PubMed  CAS  Google Scholar 

  2. Etheridge AS, Black SR, Patel PR, So J, Mathews JM (2007) An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Plant Med 73:731–741

    Article  CAS  Google Scholar 

  3. Grimm SW, Richtand NM, Winter HR, Stams KR, Reels SB (2006) Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. Br J Clin Pharmacol 61:58–69

    Article  PubMed  CAS  Google Scholar 

  4. Neuvonen PJ, Niemi M, Backman JT (2006) Drug interactions with lipid lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther 80:565–581

    Article  PubMed  CAS  Google Scholar 

  5. Ma MK, McLeod HL (2003) Lessons learnt from the irinotecan metabolic pathway. Curr Med Chem 10:41–49

    Article  PubMed  CAS  Google Scholar 

  6. Lemahieu WP, Hermann M, Asberg A, Verbeke K, Holdaas H, Vanrenterghem Y, Maes BD (2005) Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. Am J Transplant 5:2236–2243

    Article  PubMed  CAS  Google Scholar 

  7. Benet LZ, Cummins CL, Wu CY (2004) Unmasking the dynamic interplay between efflux transporters and metabolic enzymes. Int J Pharm 277:3–9

    Article  PubMed  CAS  Google Scholar 

  8. Benet LZ, Cummins CL, Wu CY (2003) Transporter-enzyme interactions:implications for predicting drug-drug interactions from in vitro data. Curr Drug Metab 4:393–398

    Article  PubMed  CAS  Google Scholar 

  9. Cummins CL, Jacobsen W, Wu CY (2002) Unmasking the dynamic interplay between intestinal P-gycoprotein and CYP3A4. J Pharmacol Exp Ther 300:1036–1045

    Article  PubMed  CAS  Google Scholar 

  10. Prakash J, Velpandian T, Pande JN, Gupta SK (2003) Serum rifampicin levels in patients with tuberculosis: effect of P-gycoprotein and CYP3A4 blockers on its absorption. Clin Drug Investig 23:463–472

    Article  PubMed  CAS  Google Scholar 

  11. Holtzman CW, Higgins BS, Spinler SA (2006) Role of P-glycoprotein in statin drug interactions. Pharmacotherapy 26:1601–1607

    Article  PubMed  CAS  Google Scholar 

  12. McDonnell CG, Shorten G, Van Pelt FN (2005) Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro. Anaesthesia 60:747–753

    Article  CAS  Google Scholar 

  13. Lemahieu WP, Maes BD, Verbeke K, Vanrenterghem Y (2005) Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation. Kidney Int 67:1152–1160

    Article  PubMed  CAS  Google Scholar 

  14. Benet LZ, Cummins CL (2001) The drug efflux-metabolism alliance: biochemical aspects. Adv Drug Deliv Rev 50:S3–S11

    Article  PubMed  CAS  Google Scholar 

  15. Hochman JH, Chiba M, Nishima J, Yamazaki M, Lin JH (2000) Influence of P-glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P450 3A4. J Pharmacol Exp Ther 292:310–318

    PubMed  CAS  Google Scholar 

  16. Custodio JM, Wu CY, Benet LZ (2008) Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv Drug Deliv Rev 60:717–733

    Article  PubMed  CAS  Google Scholar 

  17. Popovic J (2007) Validation of the hepatic blood flow rate model for verapamil first-pass metabolism. Eur J Drug Metab Pharmacokinet 32:13–19

    PubMed  CAS  Google Scholar 

  18. Shitara Y, Sugiyama Y (2006) Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther 112:71–105

    Article  PubMed  CAS  Google Scholar 

  19. Kato M, Chiba K, Hisaka A, Ishigami M, Kayama M, Mizuno N et al (2003) The intestinal first-pass metabolism of substrates of CYP3A4 and P-glycoprotein—quantitative analysis based on information from the literature. Drug Metab Pharmacokinet 18:365–372

    Article  PubMed  CAS  Google Scholar 

  20. Kantola T, Kivisto KT, Neuvonen PJ (1998) Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations. Clin Pharmacol Ther 64:177–182

    Article  PubMed  CAS  Google Scholar 

  21. Perloff ES, Duan SX, Skolnik PR, Greenblatt DJ, von Moltke LL (2005) Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro. Drug Metab Dispos 33:764–770

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Global Drug Development, ClinTec (India) International Pvt Ltd, 3rd floor, ‘A’ Wing, Divyasree Chambers, Langford Road, Bangalore, 560 025, India

    Nuggehally R. Srinivas

Authors
  1. Nuggehally R. Srinivas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nuggehally R. Srinivas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Srinivas, N.R. Dual drug interactions via P-glycoprotein (P-gp)/ cytochrome P450 (CYP3A4) interplay: recent case study of oral atorvastatin and verapamil. Eur J Clin Pharmacol 64, 1135–1136 (2008). https://doi.org/10.1007/s00228-008-0512-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-008-0512-8

Keywords

Search

Navigation